Megadyne Medical competitors

Results-focused senior executive whose strategic vision, leadership and commitment to success consistently led to dynamic gains in revenue, profit, operational performance and competitive advantage in US and global markets. Leverages instinctive ability to zero in on product and market potential to achieve objectives in start-up, turnaround and growth environments.Selected Achievements:Led $400 million division to record growth in worldwide sales and profit, with 14% year-over-year revenue gains and 10 point improvement in the bottom line.Key member of executive team that negotiated the $2.2 billion acquisition of Gyrus ACMI by Olympus Corporation.Built US division to $96.6 million in sales with average annual revenue growth of 35% for 3 consecutive years.Strategic forward thinker - initiated and spearheaded a comprehensive $700 million business restructuring to comply with changing healthcare laws and regulations while concurrently streamlining process, driving productivity and increasing customer satisfaction. The initiative resulted in a 15% reduction in expenses and a 5% revenue increase.

Matthew E. Monaghan is an independent director who joined the Board in October 2016, and is a member of the Audit Committee and Nominating and Corporate Governance Committee. Mr. Monaghan currently serves as President and Chief Executive Officer at Invacare Corporation (NYSE:IVC) (“Invacare”), a medical device manufacturer for the home and long-term healthcare markets, a position he has held since April 2015. Mr. Monaghan was named Chairman of the Invacare Board in May 2015. He previously served as Senior Vice President, Global Hips and Reconstructive Research for Zimmer Biomet Holdings, Inc. (formerly known as Zimmer Holdings, Inc.) (“Zimmer”), a global company that designs, develops, manufactures and markets orthopedic reconstructive, spinal and trauma devices, dental implants, and related surgical products from 2014 to 2015. Mr. Monaghan also has served as Operating Executive for Texas Pacific Group from 2006 to 2009 and at Cerberus Capital Management from 2003 to 2005. He started his career with 13 years in the aerospace, medical and other industrial businesses of General Electric. Mr. Monaghan is a trustee of Cleveland Clinic Avon Lake Hospital. Mr. Monaghan was a member of the board of directors of CD Diagnostics, Inc. from 2012 to 2016 and served as the chairman of the Audit Committee from 2012 to 2015 and as chairman of the board from 2015 to 2016. He holds a Bachelor’s degree in Mechanical Engineering from Cornell University, a Master’s degree in Mechanical Engineering from MIT and an MBA from INSEAD Business School in France.

Alexandre Montague is a Chief Executive Officer at Hoya Vision Care and is based in Singapore. He has worked as Vice-President, Mediterranean, Turkey, CIS, Middle East and Africa at Essilor Group; Company President at Hoya; and Managing Director Essilor France / Directeur Général Essilor France at Essilor Group. Alexandre attended University of Central Arkansas between 1991 and 1994, INSEAD between 2016 and 2017, and Keio University between 1995 and 1996.

Scott Huennekens has served as President and Chief Executive Officer since April 2002. From January 2000 to March 2002, he served as the President and Chief Executive Officer of Digirad Corporation, a medical imaging company. Mr. Huennekens is a member of the Board of Directors for Volcano Corporation, Uptake Medical, the Medical Device Manufacturers Association (MDMA), and BIOCOM. He received a B.S. in Business Administration from the University of Southern California and an M.B.A. from Harvard Business School.

Brent Eck is a Member of the Board of Directors at Kindex Pharmaceuticals. He currently serves as President and Chief Executive Officer at Metagenics.

John Voskuil currently works as John Voskuil for G&H Orthodontics. He previously worked at Consultant as Dental Industry Consultant. He attend Northern Illinois University in 1997.